Want to see AXSM full AI Analyst Report?
Axsome Therapeutics (AXSM) Ownership - Who Owns Axsome Therapeutics?
2,419 Followers
Axsome Therapeutics (AXSM) Ownership Overview
- 15.08% Insiders
- 23.75% Mutual Funds
- 1.67% Other Institutional Investors
- 13.59% ETFs
- 45.91% Public Companies and Individual Investors
The ownership structure of Axsome Therapeutics (AXSM) stock is a mix of institutional, retail, and individual investors. Approximately 39.01% of the company’s stock is owned by Institutional Investors, 15.08% is owned by Insiders, and 45.91% is owned by Public Companies and Individual Investors.
The ownership structure of Axsome Therapeutics (AXSM) stock is a mix of institutional, retail, and individual investors. Approximately 39.01% of the company’s stock is owned by Institutional Investors, 15.08% is owned by Insiders, and 45.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Perceptive Advisors Llc | $28,993,007 | |
| Jun 30, 2026 | Driehaus Capital Management Llc | $91,170,461 | |
| Jun 30, 2026 | Royce & Associates Llc | $22,284,106 | |
| Jun 30, 2026 | Entrypoint Capital, Llc | $340,475 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Tabuteau Herriot | 7,351,729 | Insider | 14.04% | 1,007,186,873 |
| Vanguard | 3,752,570 | Institution | 7.16% | 514,102,090 |
| Vanguard Index Funds | 3,466,204 | Institution | 6.62% | 474,869,948 |
| BlackRock, Inc. | 3,103,708 | Institution | 5.93% | 425,207,996 |
| Ishares | 1,609,812 | Institution | 3.07% | 220,544,244 |
| Delaware Group Equity Funds V | 1,452,975 | Institution | 2.77% | 199,057,575 |
| First Trust | 693,876 | Institution | 1.32% | 95,061,012 |
| Vanguard Explorer Fund | 531,004 | Institution | 1.01% | 72,747,548 |
| Fidelity Select Portfolios | 497,180 | Institution | 0.95% | 68,113,660 |
| Mark Coleman | 434,245 | Insider | 0.83% | 59,491,565 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 3,466,204 | Institution | 6.62% | 474,869,948 |
| Delaware Group Equity Funds V | 1,452,975 | Institution | 2.77% | 199,057,575 |
| Vanguard Explorer Fund | 531,004 | Institution | 1.01% | 72,747,548 |
| Fidelity Select Portfolios | 497,180 | Institution | 0.95% | 68,113,660 |
| Fidelity Concord Street Trust | 431,698 | Institution | 0.82% | 59,142,626 |
| Ivy Funds | 418,038 | Institution | 0.80% | 57,271,206 |
| Fidelity Salem Street Trust | 396,340 | Institution | 0.76% | 54,298,580 |
| Mutual Fund Series Trust | 330,193 | Institution | 0.63% | 45,236,441 |
| Franklin Custodian Funds | 300,000 | Institution | 0.57% | 41,100,000 |
| Fidelity Securities Fund | 262,160 | Institution | 0.50% | 35,915,920 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VTI ETF | 1,418,748 | Institution | 2.70% | 261,602,944 |
| Vanguard, VB ETF | 1,001,728 | Institution | 1.90% | 184,708,626 |
| First Trust, FBT ETF | 586,879 | Institution | 1.12% | 80,402,423 |
| Vanguard, VBK ETF | 557,023 | Institution | 1.06% | 102,709,471 |
| Vanguard, VXF ETF | 502,026 | Institution | 0.95% | 92,568,574 |
| iShares, IBB ETF | 335,638 | Institution | 0.64% | 45,982,406 |
| iShares, IWP ETF | 242,834 | Institution | 0.46% | 33,268,258 |
| Schwab, SCHA ETF | 236,597 | Institution | 0.45% | 33,031,307 |
| iShares, IWR ETF | 183,362 | Institution | 0.35% | 25,120,594 |
| iShares, IWF ETF | 162,268 | Institution | 0.31% | 22,230,716 |
FAQ
Who Owns Axsome Therapeutics (AXSM)?
According to the latest TipRanks data, approximately 39.01% of the company's stock is held by institutional investors, 15.08% is held by insiders, and 45.91% is held by public companies and individual investors.
What percentage of Axsome Therapeutics (AXSM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 39.01% of Axsome Therapeutics (AXSM) stock is held by institutional investors: 23.75% by mutual funds, 13.59% by ETFs and 1.67% by other institutional investors.
What percentage of Axsome Therapeutics (AXSM) stock is held by retail investors?
According to the latest TipRanks data, approximately 45.91% of Axsome Therapeutics (AXSM) stock is held by public companies and individual investors.
Who owns the most shares of Axsome Therapeutics (AXSM)?
TABUTEAU HERRIOT owns the most shares of Axsome Therapeutics (AXSM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
